InBioGen Co Ltd (101140) — Cash Flow Quality Index
InBioGen Co Ltd (101140) has a Cash Flow Quality Index of -0.20x as of September 2025. Operating cash flow of ₩-1.67 Billion is below net income of ₩8.17 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore InBioGen Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
InBioGen Co Ltd Cash Flow Quality Index (2018–2024)
Historical Cash Flow Quality Index for InBioGen Co Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see InBioGen Co Ltd cash conversion from operations.
Annual Cash Flow Quality Index for InBioGen Co Ltd (2018–2024)
Year-by-year earnings quality comparison for InBioGen Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | ₩-33.13 Million | ₩16.12 Billion | ▲ +97.8% |
| 2023 | -0.09x | ₩-1.05 Billion | ₩11.34 Billion | ▼ -23.3% |
| 2021 | -0.08x | ₩-7.07 Billion | ₩94.12 Billion | ▲ +74.3% |
| 2019 | -0.29x | ₩-3.83 Billion | ₩13.12 Billion | ▲ +71.4% |
| 2018 | -1.02x | ₩-1.70 Billion | ₩1.66 Billion | — |